Skip to main content

Patient Access Solutions Notice to Shareholders

Written by Customer Service on . Posted in Public Companies.

Tender Offer Extended an Additional 30 Days
COMMACK, NY, Sept. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Patient Access Solutions, Inc. (OTC PINK: PASO), a provider of technology and management solutions for the healthcare and financial industries, has amended its filing to keep the previously announced Tender Offer, originally declared in the Press Release made on September 1, 2020, available for an additional 30 days. Therefore the Tender date deadline is now no longer September 18 but rather October 16, 2020 at the close of the business day deemed to be 5:00 p.m. E.S.T.This choice to extend was made for two primary reasons. The first was due to the overwhelming number of shareholder emails and phone calls showing both concern and frustration over possibly missing the deadline to tender their shares. The Company is very pleased with this exciting initial response from our loyal shareholders that share our long term vision for meaningful success. The Company looks forward to updating our shareholders on other positive related steps and progress made associated with this restructuring in the near future. The second was it came to our attention that the original date simply did not provide ample time for the task of effectuating the Tender Offer process to be completed. This includes our Transfer Agent and all agencies involved in the entire process of shareholder notification, shareholder Tender requests being submitted and delivery of the new shares for those who choose to Tender as well as allotting appropriate time for those same steps for both DTC and the brokerage firms holding shares on the behalf of our shareholders.About Patient Access Solutions Inc.(www.pashealth.com)Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions company which has created a formidable array of technology, management resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. For more information about the services and products of Patient Access Solutions, please visit our website at www.pashealth.com. Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at http://www.sec.gov.info@pashealth.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.